Latest Breaking News On - Ready screening cohort study - Page 1 : comparemela.com

/PRNewswire/ Aspen Neuroscience today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application,.

San diegoUnited statesAndres brattFaheem hasnainJeanne loringDamien mcdevittDrug administrationScripps research instituteDepartment of molecular medicineAspen neuroscience incAspen will initiate first multicenter phaseClinical trialInvestigational new drugReady screening cohort studyProfessor emeritusRegenerative medicine